Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug;87(8):3043-3055.
doi: 10.1111/bcp.14752. Epub 2021 Feb 20.

Drug-induced peripheral oedema: An aetiology-based review

Affiliations
Free article
Review

Drug-induced peripheral oedema: An aetiology-based review

Bérenger Largeau et al. Br J Clin Pharmacol. 2021 Aug.
Free article

Abstract

Many drugs are responsible, through different mechanisms, for peripheral oedema. Severity is highly variable, ranging from slight oedema of the lower limbs to anasarca pictures as in the capillary leak syndrome. Although most often noninflammatory and bilateral, some drugs are associated with peripheral oedema that is readily erythematous (eg, pemetrexed) or unilateral (eg, sirolimus). Thus, drug-induced peripheral oedema is underrecognized and misdiagnosed, frequently leading to a prescribing cascade. Four main mechanisms are involved, namely precapillary arteriolar vasodilation (vasodilatory oedema), sodium/water retention (renal oedema), lymphatic insufficiency (lymphedema) and increased capillary permeability (permeability oedema). The underlying mechanism has significant impact on treatment efficacy. The purpose of this review is to provide a comprehensive analysis of the main causative drugs by illustrating each pathophysiological mechanism and their management through an example of a drug.

Keywords: capillary permeability; lymphedema; microcirculation; oedema; pharmacovigilance; renal reabsorption.

PubMed Disclaimer

References

REFERENCES

    1. D'Angelo SP, Kris MG, Pietanza MC, Rizvi NA, Azzoli CG. A case series of dose-limiting peripheral edema observed in patients treated with pemetrexed. J Thorac Oncol. 2011;6(3):624-626. https://doi.org/10.1097/JTO.0b013e318207f788
    1. Rashid-Farokhi F, Afshar H. Lymphedema of the transplanted kidney and abdominal wall with ipsilateral pleural effusion following kidney biopsy in a patient treated with sirolimus: A case report and review of the literature. Am J Case Rep. 2017;18:1370-1376. https://doi.org/10.12659/ajcr.905962
    1. Sica DA. Calcium channel blocker-related periperal edema: can it be resolved? J Clin Hypertens (Greenwich). 2003;5(4):291-294297. https://doi.org/10.1111/j.1524-6175.2003.02402.x
    1. Page RL, O'Bryant CL, Cheng D, et al. Drugs that may cause or exacerbate heart failure: A scientific statement from the American Heart Association. Circulation. 2016;134(6):e32-e69. https://doi.org/10.1161/CIR.0000000000000426
    1. Markowitz GS, Bomback AS, Perazella MA. Drug-induced glomerular disease: direct cellular injury. Clin J Am Soc Nephrol. 2015;10(7):1291-1299. https://doi.org/10.2215/CJN.00860115

Substances

LinkOut - more resources